Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells

Active anti-cancer immune responses depend on efficient presentation of tumor antigens and co-stimulatory signals by antigen-presenting cells (APCs). Therapy with autologous natural APCs is costly and time-consuming and results in variable outcomes in clinical trials. Therefore, development of artif...

Descripción completa

Detalles Bibliográficos
Autores principales: Eggermont, Loek J., Paulis, Leonie E., Tel, Jurjen, Figdor, Carl G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Publishers 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154451/
https://www.ncbi.nlm.nih.gov/pubmed/24998519
http://dx.doi.org/10.1016/j.tibtech.2014.06.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154451/
https://www.ncbi.nlm.nih.gov/pubmed/24998519
http://dx.doi.org/10.1016/j.tibtech.2014.06.007

Ejemplares similares